However, treatment-related muscle loss and weight regain after discontinuation have been reported, highlighting the need for further research to elucidate the potential adverse effects associated with long-term use.[7] Sarcopenia is defined as the loss of skeletal muscle mass and function, most commonly observed in older adults.[8] In contrast, obesity is diagnosed in individuals with a body mass index of 30 kg/m 2 or higher and can occur across all age groups
But now there's a new option: oral semaglutide, which is available as a daily tablet
Alex Oshmyansky with a vision to manufacture drugs that nobody else wanted to bother with
The Dangers of Ozempic, Wegovy, Rybelsus, and Other Weight Loss Drugs Ozempic, Wegovy, Rybelsus, manufactured by Novo Nordisk, as well as similar weight loss drugs like Mounjaro and Trulicity, manufactured by Eli Lilly and Company, carry potentially serious health risks
We can do a very easy test called an ankle-brachial index, where we determine the blood pressure on the arms and on the legs to determine if you have it. How people experience peripheral artery disease is highly variable, Bonaca notes